Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT01011127
Different Metabolic Effects of Statins
0
Enrollment(s)
1
Study location(s)
Observational
Hypercholesterolemia
Completed
NCT00134160
OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
1,000
Enrollment(s)
2
Study location(s)
Interventional (Phase IV)
Hypertension
Cardiovascular Diseases
Completed
NCT00914524
Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy
49
Enrollment(s)
0
Study location(s)
Interventional (Phase II)
Chronic Glomerulonephritis
Diabetic Nephropathy
Completed
NCT00872586
Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
304
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00856271
Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension
287
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00107523
Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
0
Enrollment(s)
2
Study location(s)
Interventional (Phase I)
Leukemia
Completed
NCT00385944
The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)
56
Enrollment(s)
2
Study location(s)
Interventional (Phase II)
Acute Coronary Syndrome
Completed
NCT00097591
A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
13,619
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Coronary Arteriosclerosis
Acute Coronary Syndromes
101
102
103
104
105